Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
Would you treat a patient with an N2 ipsilateral recurrence following re-resection of bronchial stump recurrence?
Related Questions
In a patient who underwent cryoablation for early NSCLC, is there a role for giving preemptive further local therapy?
Is there a concern for using FFF beams in single isocenter multi target lung SBRT?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
Do you recommend consolidation immunotherapy after SBRT or surgery and chemo for T1-T2N0 SCLC?
How does metaplastic thymoma histology impact your decision regarding adjuvant radiation?
Do you use an LAD constraint in the setting of BID thoracic radiation for SCLC?
Would the presence of an SVC stent affect your decision to offer BID vs once-daily chemoradiation for SCLC?
Is there a role for the addition of radiation to preoperative chemoimmunotherapy in NSCLC with limited N2 disease planned for surgery?
Do you restrict the dose rate during treatment delivery to a pacemaker in addition to limiting the Dmax?
Would you offer SBRT for primary pulmonary adenoid cystic carcinoma in a patient who was medically not a surgical candidate?
